|Titre :||Advocating for needle and syringe exchange programmes in prisons|
|Type de document :||Rapport|
|Editeur :||London : HRI (Harm Reduction International), 2012|
|Collection :||Evidence and advocacy briefings series|
|Format :||4 p.|
|Discipline :||PRE (Prévention / Prevention)|
Thésaurus TOXIBASEPRISON ; REDUCTION DES RISQUES ; ECHANGE DE SERINGUES ; PROGRAMME ; EFFICACITE
Imprisonment is a common experience for people who use drugs. Approximately 56-90% of people who use drugs will spend time in prisons for a variety of crimes including drug use, possession, trafficking and sale, as well as for acquisitive crimes committed to support drug use. In many countries around the world, the growth of prison populations and resulting overcrowding has been attributed to the police campaigns to arrest and prosecute drug offenders.
Evidence-based prison health programmes, including harm reduction interventions such as needle and syringe programmes (NSPs) and opioid substitution therapy (OST), significantly reduce drug-related harms among vulnerable populations. Since the early 1990s, an increasing number of countries have introduced these interventions to reduce HIV and HCV in prisons. iii However, the acceptance of harm reduction measures in places of detention has been difficult in most countries. This is often linked to the assumption on the part of policy-makers that such interventions are unsafe or inappropriate in closed environments.
This briefing provides answers to some of the most commonly encountered questions when advocating for harm reduction in prisons and places of detention.
|Domaine :||Drogues illicites / Illicit drugs|
|Sous-type de document :||Lettre d'information / Newsletter|
|Refs biblio. :||17|